We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The motion for a gag order alleges DeWine and attorneys Mike Moore and Burton LeBlanc conspired to use misleading and inflammatory pronouncements to taint potential jury pools. Read More
The FDA is considering new formats to replace the five-digit National Drug Code (NDC) and drugmakers — at least those who commented on the agency’s proposals — prefer extending the code to 12 digits. Read More
A Connecticut Superior Court judge dismissed dozens of lawsuits by cities and towns in the state against Purdue and other drugmakers for their alleged role in the opioid crisis. Read More
A joint FDA advisory committee voted 19 to two on Friday in favor of the benefit-risk profile of Takeda’s Uloric (febuxostat) for treatment of excessive uric acid in the blood of gout patients. Read More
U.S. District Judge Theodore Chuang shot down the defendants’ arguments that a recent Supreme Court decision protecting foreign firms against U.S. lawsuits also extended to domestic corporations, allowing the litigation to go forward. Read More
Sen. Bernie Sanders (I-Vt.) was joined by Reps. Elijah Cummings (D-Md.), Ro Khanna (D-Calif.) and other Democrat lawmakers Thursday to announce new legislation aimed at curbing high drug prices in the U.S. Read More
The Supreme Court declined to consider Merck’s appeal of a California court ruling that overturned a $200 million jury award against Gilead over a hepatitis C drug patent. Read More